A
Athenex
Biotech & Life Sciences · Buffalo, United States · Founded 2003 · IPO 2017
Talent graph
Athenex's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Athenex's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Athenex has talent and traffic
team presence
Patent intelligence
Athenex’s patent portfolio
37 active families in the valuation dataset.
Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.
Capital deployed
Athenex's 3 investments and acquisitions.
Every disclosed deal where Athenex appeared as a backer or acquirer, 2014–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Athenex's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Athenex's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Athenex
An AI-synthesized read of the highest-engagement posts about Athenex on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Athenex on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.